Giacobello Scott M.
CHIEF FINANCIAL OFFICER at WHWK; Chief Financial Officer at GW PHARMACEUTICALS PLC
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Apr 16, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- WHWKAadi Bioscience, Inc.CHIEF FINANCIAL OFFICER
- GW PHARMACEUTICALS PLCChief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- WHWK224,000 shares
- GW PHARMACEUTICALS PLC15,528 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale GW PHARMACEUTICALS PLCUnusualFeb 26, 2019 2019
Sold 5,232 shares at $12.45 ($65k)
Giacobello Scott M., Chief Financial Officer
Sold 33.2% of holdings ($196k position)10,536 shares leftFirst sale on recordFiling
- 2 Form 4 sale GW PHARMACEUTICALS PLCPlan not statedMay 20, 2019 +83 days
Sold 4,224 shares at $14.52 ($61k)
Giacobello Scott M., Chief Financial Officer
Sold 4.6% of holdings ($1.3M position)87,096 shares leftFiling
- 3 Form 4 sale GW PHARMACEUTICALS PLCPlan not statedFeb 26, 2020 +282 days
Sold 3,852 shares at $9.17 ($35k)
Giacobello Scott M., Chief Financial Officer
Sold 4.4% of holdings ($799k position)83,244 shares leftFiling
- 4 Form 4 sale GW PHARMACEUTICALS PLCPlan not statedMar 2, 2020 +5 days
Sold 2,220 shares at $8.34 ($19k)
Giacobello Scott M., Chief Financial Officer
Sold 2.7% of holdings ($694k position)81,024 shares left0.5x usual sizeFiling
- 5 Form 4 sale WHWKNo planMar 3, 2025 +1827 days
Sold 2,806 shares at $2.35 ($7k)
Giacobello Scott M., CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 10.5% of holdings ($63k position)23,944 shares leftFirst sale on recordFollows a Form 144Filing
- 6 Form 144 notice WHWKNoticeMar 3, 2025 same day
Filed to sell 2,806 shares ($7k)
Giacobello Scott M., Officer
No 10b5-1 planFirst sale on recordFiling
- 7 Form 4 sale WHWKNo planMar 2, 2026 +364 days
Sold 2,594 shares at $3.31 ($9k)
Giacobello Scott M., CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 8.5% of holdings ($102k position)28,100 shares leftFiling
- 8 Form 4 sale WHWKUnusualApr 16, 2026 +45 days
Sold 218,600 shares at $4.03 ($882k)
Giacobello Scott M., CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 42.5% of holdings ($2.1M position)295,224 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Apr 17, 2026 | WHWK | CHIEF FINANCIAL OFFICER | Form 4 sale | 218,600 | $882k | 42.5% | Unusual | SEC |
| Mar 2, 2026 | Mar 10, 2026 | WHWK | CHIEF FINANCIAL OFFICER | Form 4 sale | 2,594 | $9k | 8.5% | No plan | SEC |
| Mar 3, 2025 | Mar 3, 2025 | WHWK | Officer | Form 144 notice | 2,806 | $7k | Notice | SEC | |
| Mar 3, 2025 | Mar 3, 2025 | WHWK | CHIEF FINANCIAL OFFICER | Form 4 sale | 2,806 | $7k | 10.5% | No plan | SEC |
| Mar 2, 2020 | Mar 4, 2020 | GW PHARMACEUTICALS PLC | Chief Financial Officer | Form 4 sale | 2,220 | $19k | 2.7% | Plan not stated | SEC |
| Feb 26, 2020 | Feb 28, 2020 | GW PHARMACEUTICALS PLC | Chief Financial Officer | Form 4 sale | 3,852 | $35k | 4.4% | Plan not stated | SEC |
| May 20, 2019 | May 21, 2019 | GW PHARMACEUTICALS PLC | Chief Financial Officer | Form 4 sale | 4,224 | $61k | 4.6% | Plan not stated | SEC |
| Feb 26, 2019 | Feb 28, 2019 | GW PHARMACEUTICALS PLC | Chief Financial Officer | Form 4 sale | 5,232 | $65k | 33.2% | Unusual | SEC |